Mary-Ellen Lynall
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mary-Ellen Lynall has a total of 145 co-authors. Here are the top co-authors by number of shared publications:
- Edward Thomas Bullmore
Department of Psychiatry, University of Cambridge
7 shared publications Edward Bullmore
Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom
3 shared publicationsMenna R. Clatworthy
Molecular Immunity Unit, University of Cambridge Department of Medicine, Cambridge, UK
3 shared publications- Menna R. Clatworthy
Molecular Immunity Unit, University of Cambridge Department of Medicine, Cambridge, UK
3 shared publications - Stacey L. Kigar
Molecular and Cellular Pharmacology Training Program, University of Wisconsin-Madison, United States
3 shared publications Abdel G. Elkahloun
Microarrays and Single-Cell Genomics, National Human Genome Research Institute, Bethesda, USA
2 shared publications
Latest Publications
- Open Access
Polygenic effects on cortical size and ADHD converge on a mid-gestational progenitor-to-neuron transition programme
Neurodevelopmental and psychiatric conditions have long been hypothesised to emerge from changes in the structure and function of the brain. However, the molecular and cellular mechanisms linking brain structure to these conditions remain unknown. Here, using genetic and structural/diffusion neuroimaging data from 59,283 individuals spanning adults, children and neonates, we identify widespread genetic associations between ADHD, anxiety and depression and multiple phenotypes indexing cortical size and subcortical volume. Multivariate genetic analyses demonstrate that these associations are largely driven by a common cortical size genetic factor and ADHD. Mendelian randomisation indicates that genetically predicted reduced cortical size is causal for ADHD and not vice versa . Using single-nucleus RNA sequencing of the developing cortex, we further demonstrate that although cortical size and ADHD are enriched in different cell types - proliferating progenitors and postmitotic neurons, respectively, they converge on neurogenic genetic programmes active during the transition between the two cell types. This programme peaks at mid-gestation and is localised to the outer subventricular and intermediate zones, the regions where progenitor amplification and early neuronal migration drive human cortical expansion, and is enriched for genes that are differentially expressed in human and macaque developing cortex. Separately, the negative genetic correlation between ADHD and cortical size measures are strongest in cortical regions that have expanded most in humans relative to macaques. Together, these findings identify a novel, spatiotemporally restricted molecular mechanism underlying neurogenesis that is enriched for polygenic effects of both cortical size and ADHD.
Open AccessPolygenic effects on cortical size and ADHD converge on a mid-gestational progenitor-to-neuron transition programme
Neurodevelopmental and psychiatric conditions have long been hypothesised to emerge from changes in the structure and function of the brain. However, the molecular and cellular mechanisms linking brain structure to these conditions remain unknown. Here, using genetic and structural/diffusion neuroimaging data from 59,283 individuals spanning adults, children and neonates, we identify widespread genetic associations between ADHD, anxiety and depression and multiple phenotypes indexing cortical size and subcortical volume. Multivariate genetic analyses demonstrate that these associations are largely driven by a common cortical size genetic factor and ADHD. Mendelian randomisation indicates that genetically predicted reduced cortical size is causal for ADHD and not vice versa . Using single-nucleus RNA sequencing of the developing cortex, we further demonstrate that although cortical size and ADHD are enriched in different cell types - proliferating progenitors and postmitotic neurons, respectively, they converge on neurogenic genetic programmes active during the transition between the two cell types. This programme peaks at mid-gestation and is localised to the outer subventricular and intermediate zones, the regions where progenitor amplification and early neuronal migration drive human cortical expansion, and is enriched for genes that are differentially expressed in human and macaque developing cortex. Separately, the negative genetic correlation between ADHD and cortical size measures are strongest in cortical regions that have expanded most in humans relative to macaques. Together, these findings identify a novel, spatiotemporally restricted molecular mechanism underlying neurogenesis that is enriched for polygenic effects of both cortical size and ADHD.
- Open Access
The dynamics of glutamate receptor subunit GluN1 concentration in urinary astrocyte-derived extracellular vesicles from a patient with anti-NMDAR encephalitis
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis involves dynamic changes in glutamatergic signalling. Magnetic resonance spectroscopy can monitor these changes but lacks temporal resolution and cell-type specificity. We investigated whether urinary astrocyte-derived extracellular vesicles (ADEVs) could serve as a non-invasive proxy for brain receptor dynamics. We prospectively collected longitudinal urine and cerebrospinal fluid (CSF) samples from a 30–35-year-old female patient during 34 days of treatment. We isolated ADEVs using a specific protocol and measured GluN1 protein levels. A 30–35-year-old healthy female provided control samples. Wavelet transform analysis of the patient’s GluN1 time series revealed two distinct patterns. First, a low-frequency trend showed declining GluN1 levels over the treatment period, which mirrored the reduction in CSF GluN1 concentrations. Second, a high-frequency oscillation appeared to be coupled with methotrexate infusions, with GluN1 peaks occurring approximately 48 hours after each dose. This secondary increase may reflect drug-induced p53 activation, which promotes the exosomal release of internalised receptors. These findings suggest that urinary ADEVs provide a feasible and informative method to monitor real-time molecular fluxes in the brain.
Open AccessThe dynamics of glutamate receptor subunit GluN1 concentration in urinary astrocyte-derived extracellular vesicles from a patient with anti-NMDAR encephalitis
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis involves dynamic changes in glutamatergic signalling. Magnetic resonance spectroscopy can monitor these changes but lacks temporal resolution and cell-type specificity. We investigated whether urinary astrocyte-derived extracellular vesicles (ADEVs) could serve as a non-invasive proxy for brain receptor dynamics. We prospectively collected longitudinal urine and cerebrospinal fluid (CSF) samples from a 30–35-year-old female patient during 34 days of treatment. We isolated ADEVs using a specific protocol and measured GluN1 protein levels. A 30–35-year-old healthy female provided control samples. Wavelet transform analysis of the patient’s GluN1 time series revealed two distinct patterns. First, a low-frequency trend showed declining GluN1 levels over the treatment period, which mirrored the reduction in CSF GluN1 concentrations. Second, a high-frequency oscillation appeared to be coupled with methotrexate infusions, with GluN1 peaks occurring approximately 48 hours after each dose. This secondary increase may reflect drug-induced p53 activation, which promotes the exosomal release of internalised receptors. These findings suggest that urinary ADEVs provide a feasible and informative method to monitor real-time molecular fluxes in the brain.
- Open Access
- 31 March 2026
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 98, 102467
Immune dysfunction in psychiatric disorders: emerging genomic insights
- 31 March 2026
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 98, 102467
Open AccessImmune dysfunction in psychiatric disorders: emerging genomic insights
- Open Access
- 17 January 2026
- Published by Center for Open Science in PsyArXiv
Immune dysfunction in psychiatric disorders: emerging genomic insights
Psychiatric disorders are polygenic conditions of the mind and brain, yet immune associations emerge across genetic and molecular studies. Some immune signals may reflect assay bias or illness effects; immunogenetic approaches help disentangle cause and correlation. Genetic associations in the extended major histocompatibility complex (MHC) remain of unclear relevance to immunopathogenesis but warrant finer-resolution analysis. Integrating non-MHC risk variants with immunological data especially implicates adaptive immune cells in psychiatric pathogenesis. Epigenetic studies show that resting immune cells carry a ‘poised’ landscape encoding past exposures and predicting future responses, illuminating how genetic variability shapes illness risk from environmental insults such as stress and infection. While only some patients may have immune-driven symptoms, the tractability and accessibility of the immune system make it a compelling focus for stratification and therapeutics.
- 17 January 2026
- Published by Center for Open Science in PsyArXiv
Open AccessImmune dysfunction in psychiatric disorders: emerging genomic insights
Psychiatric disorders are polygenic conditions of the mind and brain, yet immune associations emerge across genetic and molecular studies. Some immune signals may reflect assay bias or illness effects; immunogenetic approaches help disentangle cause and correlation. Genetic associations in the extended major histocompatibility complex (MHC) remain of unclear relevance to immunopathogenesis but warrant finer-resolution analysis. Integrating non-MHC risk variants with immunological data especially implicates adaptive immune cells in psychiatric pathogenesis. Epigenetic studies show that resting immune cells carry a ‘poised’ landscape encoding past exposures and predicting future responses, illuminating how genetic variability shapes illness risk from environmental insults such as stress and infection. While only some patients may have immune-driven symptoms, the tractability and accessibility of the immune system make it a compelling focus for stratification and therapeutics.
- Open Access
Inflammatory profiles of transdiagnostic symptom dimensions in healthy females
Background: Psychiatric disorders are increasingly conceptualised as heterogeneous categories with transdiagnostic underlying mechanisms that cut across multiple diagnoses and vary within a single diagnosis. Inflammation induced by psychosocial stress is one particularly potent example: previous research suggests that inflammatory profiles may correspond to symptom subgroups rather than traditional diagnostic categories. However, robust identification of transdiagnostic symptoms linked to specific inflammatory profiles remains rare. In this study, we examined the relationship between inflammatory profiles (at baseline and after a stress induction) and transdiagnostic symptom dimensions in females, who show higher prevalence of stress-related disorders such as anxiety and depression. Methods: A modest but relatively homogenous healthy female sample, between the ages of 18 and 35, was recruited (N=26). We obtained venous blood samples, at baseline and after a combined physiological and social stress induction, to measure full blood counts, plasma cytokines and peripheral blood mononuclear cells (PBMCs; for cell stimulation and intracellular flow cytometry analysis). Participants completed a battery of psychiatric self-report questions, from which we modelled three transdiagnostic factor scores. Finally, we used Bayesian regressions to evaluate the predictive contribution of transdiagnostic factors to inflammatory markers (at baseline and stress-induced), as well as to the principal components of inflammatory measures (derived from a principal component analysis (PCA) of the inflammatory data). Results: We identified specific relationships between inflammatory profiles and transdiagnostic symptom dimensions. Higher scores on a ‘social withdrawal’ factor were associated with greater baseline neutrophil (95% highest density interval (HDI) = [0.06, 1.32]; BF 10 = 2.92) and monocyte counts (95% HDI = [0.29, 1.46]; BF 10 = 19.08), whereas higher ‘anxious-depression’ scores were associated with a lower baseline monocyte count (95% HDI = [−0.96, −0.02]; BF 10 = 1.81) and a greater inflammatory response to stress (e.g., change in neutrophil scores from pre- to post stress induction: (95% HDI = [0.18, 2.14]); BF 10 = 5.66). We also found evidence for an association between the ‘social withdrawal’ factor and an immune principal component most strongly weighted by monocytes, basophils, and IL-6 (95% HDI = [−1.14, −0.01]; BF 10 = 1.88). Conclusions: We find preliminary evidence that different transdiagnostic psychiatric symptom dimensions map onto specific inflammatory profiles, both at baseline and after a stress induction. This represents a proof-of-principle for the use of data-driven and hypothesis-driven approaches to identify and link transdiagnostic factors with inflammatory changes, which may be of use to future studies with larger, clinical populations, or for testing in the context of stratified interventions.
Open AccessInflammatory profiles of transdiagnostic symptom dimensions in healthy females
Background: Psychiatric disorders are increasingly conceptualised as heterogeneous categories with transdiagnostic underlying mechanisms that cut across multiple diagnoses and vary within a single diagnosis. Inflammation induced by psychosocial stress is one particularly potent example: previous research suggests that inflammatory profiles may correspond to symptom subgroups rather than traditional diagnostic categories. However, robust identification of transdiagnostic symptoms linked to specific inflammatory profiles remains rare. In this study, we examined the relationship between inflammatory profiles (at baseline and after a stress induction) and transdiagnostic symptom dimensions in females, who show higher prevalence of stress-related disorders such as anxiety and depression. Methods: A modest but relatively homogenous healthy female sample, between the ages of 18 and 35, was recruited (N=26). We obtained venous blood samples, at baseline and after a combined physiological and social stress induction, to measure full blood counts, plasma cytokines and peripheral blood mononuclear cells (PBMCs; for cell stimulation and intracellular flow cytometry analysis). Participants completed a battery of psychiatric self-report questions, from which we modelled three transdiagnostic factor scores. Finally, we used Bayesian regressions to evaluate the predictive contribution of transdiagnostic factors to inflammatory markers (at baseline and stress-induced), as well as to the principal components of inflammatory measures (derived from a principal component analysis (PCA) of the inflammatory data). Results: We identified specific relationships between inflammatory profiles and transdiagnostic symptom dimensions. Higher scores on a ‘social withdrawal’ factor were associated with greater baseline neutrophil (95% highest density interval (HDI) = [0.06, 1.32]; BF 10 = 2.92) and monocyte counts (95% HDI = [0.29, 1.46]; BF 10 = 19.08), whereas higher ‘anxious-depression’ scores were associated with a lower baseline monocyte count (95% HDI = [−0.96, −0.02]; BF 10 = 1.81) and a greater inflammatory response to stress (e.g., change in neutrophil scores from pre- to post stress induction: (95% HDI = [0.18, 2.14]); BF 10 = 5.66). We also found evidence for an association between the ‘social withdrawal’ factor and an immune principal component most strongly weighted by monocytes, basophils, and IL-6 (95% HDI = [−1.14, −0.01]; BF 10 = 1.88). Conclusions: We find preliminary evidence that different transdiagnostic psychiatric symptom dimensions map onto specific inflammatory profiles, both at baseline and after a stress induction. This represents a proof-of-principle for the use of data-driven and hypothesis-driven approaches to identify and link transdiagnostic factors with inflammatory changes, which may be of use to future studies with larger, clinical populations, or for testing in the context of stratified interventions.
- Open Access
- 29 September 2025
- Published by Elsevier in Biological Psychiatry
- Vol. 99 (12) , 1130-1140
Systematic Review and Mega-Analysis of the Peripheral Blood Transcriptome in Depression Implicates Dysregulation of Lymphoid Cells and Histones
- 29 September 2025
- Published by Elsevier in Biological Psychiatry
- Vol. 99 (12) , 1130-1140
Open AccessSystematic Review and Mega-Analysis of the Peripheral Blood Transcriptome in Depression Implicates Dysregulation of Lymphoid Cells and Histones
- Open Access
- 1 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
Chronic social defeat stress induces meningeal neutrophilia via type I interferon signaling in male mice
Inflammation is increasingly recognized as a risk factor for psychiatric disorders. Animal models of stress and stress-related disorders are associated with blood neutrophilia. The mechanistic relevance of this to symptoms or behavior is unclear. We characterized the immune response to chronic social defeat (CSD) stress at brain border regions in male mice. Here we show that chronic, but not acute, stress causes neutrophil accumulation in the meninges—i.e., “meningeal neutrophilia”— but not the brain. CSD promotes neutrophil trafficking to meninges via vascular channels originating from skull bone marrow (BM). Transcriptional analysis suggests CSD increases type I interferon (IFN-I) signaling in meningeal neutrophils. Blocking this pathway via the IFN-I receptor (IFNAR) protects against the negative behavioral effects of CSD stress. Our identification of IFN-I signaling as a putative mediator of meningeal neutrophil recruitment may facilitlate development of new therapies for stress-related disorders.
- 1 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
Open AccessChronic social defeat stress induces meningeal neutrophilia via type I interferon signaling in male mice
Inflammation is increasingly recognized as a risk factor for psychiatric disorders. Animal models of stress and stress-related disorders are associated with blood neutrophilia. The mechanistic relevance of this to symptoms or behavior is unclear. We characterized the immune response to chronic social defeat (CSD) stress at brain border regions in male mice. Here we show that chronic, but not acute, stress causes neutrophil accumulation in the meninges—i.e., “meningeal neutrophilia”— but not the brain. CSD promotes neutrophil trafficking to meninges via vascular channels originating from skull bone marrow (BM). Transcriptional analysis suggests CSD increases type I interferon (IFN-I) signaling in meningeal neutrophils. Blocking this pathway via the IFN-I receptor (IFNAR) protects against the negative behavioral effects of CSD stress. Our identification of IFN-I signaling as a putative mediator of meningeal neutrophil recruitment may facilitlate development of new therapies for stress-related disorders.
- Open Access
Decoding Treatment Choice: Genetic and Phenotypic Analyses of Long-term Antidepressant Acceptability
Importance: Antidepressant treatment remains largely trial-and-error, with approximately one-third of patients with major depressive disorder (MDD) reporting inefficacy of first-line medications. Identifying predictors of treatment acceptability is needed to improve prescribing precision and patient outcomes. Objective: To identify phenotypic and genetic signatures associated with antidepressant acceptability and treatment complexity. Design, Setting, and Participants: Retrospective cohort study of Australian Genetics of Depression Study participants dispensing ≥1 prescription of the 10 most commonly used antidepressants, based on linked 4.5-year (2013–2017) prescription data. Exposures: Treatment complexity was assessed as number of antidepressant classes dispensed. Antidepressant acceptability was defined as sustained single-antidepressant use (≥360 cumulative days). Participants with genotyping data were classified into mutually exclusive groups based on sustained single-medication use. Main Outcomes and Measures: Associations with 40 phenotypes and polygenic scores (PGS) for 15 traits. Genome-wide association studies (GWAS) were conducted for SSRI and SSRI/SNRI antidepressant acceptability. Results: Of 13,763 participants with ≥1 antidepressant prescription, 9,844 had genotyping data (mean [SD] age 44.5 [15.0] years; 26% male; 89% lifetime MDD). Treatment complexity was significantly associated with 27 of 40 phenotypes (e.g., smoking, recurrent MDD, suicidal ideation, chronic pain, BMI) and higher PGSs for psychiatric traits (MDD, ADHD, bipolar disorder, neuroticism; β = 0.028– 0.045 per PGS SD unit, p = 9.9 × 10 -6 to 2.1 × 10 -10 ). Sixty percent met criteria for an exclusive antidepressant acceptability group. These groups had distinct phenotypic profiles, including associations with BMI, suicidal ideation, and comorbidities. In particular, only SNRI users had higher BMI than SSRI users, but this association was explained by the BMI PGS, indicating genetic rather than treatment-induced differences. GWAS identified novel loci including an immune-related gene LY9 , for which the G allele of rs6427545 was associated with reduced SSRI acceptability (frequency = 0.31; OR = 0.82; p = 2.8 × 10 -8 ) Conclusions and Relevance: Antidepressant acceptability and complex treatment patterns correspond to distinct phenotypic and genetic signatures. PGS demonstrate potential for enabling precision psychiatry, and immune-related pathways warrant therapeutic investigation. Key Points: Question: Can phenotypic and genetic factors help identify individuals likely to show antidepressant-specific acceptability and treatment complexity, improving treatment precision in major depressive disorder (MDD)? Findings: In this cohort study of 13,763 individuals with antidepressant prescriptions, treatment complexity was associated with 27 self-reported phenotypic traits and higher polygenic scores (PGS) for psychiatric conditions. Among 9,844 genotyped participants, 60% met criteria for single-antidepressant acceptability, with distinct phenotypic and genetic profiles. Notably, higher BMI among sustained SNRI users was explained by genetic predisposition. A genome-wide association study identified novel loci, including an immune-related gene ( LY9 ), associated with reduced SSRI acceptability. Meaning: Phenotypic and genetic factors, including PGS, are associated with both antidepressant acceptability and treatment complexity. These findings support the use of such markers to guide treatment selection and identify patients at risk for more complex courses, informing precision psychiatry and early intervention in MDD.
Open AccessDecoding Treatment Choice: Genetic and Phenotypic Analyses of Long-term Antidepressant Acceptability
Importance: Antidepressant treatment remains largely trial-and-error, with approximately one-third of patients with major depressive disorder (MDD) reporting inefficacy of first-line medications. Identifying predictors of treatment acceptability is needed to improve prescribing precision and patient outcomes. Objective: To identify phenotypic and genetic signatures associated with antidepressant acceptability and treatment complexity. Design, Setting, and Participants: Retrospective cohort study of Australian Genetics of Depression Study participants dispensing ≥1 prescription of the 10 most commonly used antidepressants, based on linked 4.5-year (2013–2017) prescription data. Exposures: Treatment complexity was assessed as number of antidepressant classes dispensed. Antidepressant acceptability was defined as sustained single-antidepressant use (≥360 cumulative days). Participants with genotyping data were classified into mutually exclusive groups based on sustained single-medication use. Main Outcomes and Measures: Associations with 40 phenotypes and polygenic scores (PGS) for 15 traits. Genome-wide association studies (GWAS) were conducted for SSRI and SSRI/SNRI antidepressant acceptability. Results: Of 13,763 participants with ≥1 antidepressant prescription, 9,844 had genotyping data (mean [SD] age 44.5 [15.0] years; 26% male; 89% lifetime MDD). Treatment complexity was significantly associated with 27 of 40 phenotypes (e.g., smoking, recurrent MDD, suicidal ideation, chronic pain, BMI) and higher PGSs for psychiatric traits (MDD, ADHD, bipolar disorder, neuroticism; β = 0.028– 0.045 per PGS SD unit, p = 9.9 × 10 -6 to 2.1 × 10 -10 ). Sixty percent met criteria for an exclusive antidepressant acceptability group. These groups had distinct phenotypic profiles, including associations with BMI, suicidal ideation, and comorbidities. In particular, only SNRI users had higher BMI than SSRI users, but this association was explained by the BMI PGS, indicating genetic rather than treatment-induced differences. GWAS identified novel loci including an immune-related gene LY9 , for which the G allele of rs6427545 was associated with reduced SSRI acceptability (frequency = 0.31; OR = 0.82; p = 2.8 × 10 -8 ) Conclusions and Relevance: Antidepressant acceptability and complex treatment patterns correspond to distinct phenotypic and genetic signatures. PGS demonstrate potential for enabling precision psychiatry, and immune-related pathways warrant therapeutic investigation. Key Points: Question: Can phenotypic and genetic factors help identify individuals likely to show antidepressant-specific acceptability and treatment complexity, improving treatment precision in major depressive disorder (MDD)? Findings: In this cohort study of 13,763 individuals with antidepressant prescriptions, treatment complexity was associated with 27 self-reported phenotypic traits and higher polygenic scores (PGS) for psychiatric conditions. Among 9,844 genotyped participants, 60% met criteria for single-antidepressant acceptability, with distinct phenotypic and genetic profiles. Notably, higher BMI among sustained SNRI users was explained by genetic predisposition. A genome-wide association study identified novel loci, including an immune-related gene ( LY9 ), associated with reduced SSRI acceptability. Meaning: Phenotypic and genetic factors, including PGS, are associated with both antidepressant acceptability and treatment complexity. These findings support the use of such markers to guide treatment selection and identify patients at risk for more complex courses, informing precision psychiatry and early intervention in MDD.
- Open Access
Systematic review and mega-analysis of the peripheral blood transcriptome in depression implicates dysregulation of lymphoid cells and histones
Background: Depression has been associated with transcriptomic changes in peripheral blood. However, the contribution of specific immune cell subsets or pathways remains unclear, and findings have been variable across previous studies, which have not tended to account for sample cellular composition. Methods: We performed a systematic review of peripheral blood transcriptome studies in depression. For the five datasets meeting criteria (total N=6,011), we performed harmonized reprocessing and cell-composition-adjusted differential gene and transcript analyses, followed by a bias- and inflation-adjusted weighted Z-score mega-analysis. We investigated the biological pathways and cell subsets implicated by the results. We also performed a sex-stratified gene network mega-analysis using consensus weighted gene co-expression network analysis (WGCNA). Results: Few genes showed robust differential gene expression (DGE) in depression. Depression was reproducibly associated with decreases in replication-dependent histones, and with a decrease in oxidative phosphorylation pathways in females only. Cell source analyses implicated lymphoid cells (T cells and NK cells) as likely contributors to the depression differential expression signature. WGCNA mega-analysis revealed multiple consensus modules associated with depression, with a PUF60 -related module upregulated in both female and male depression in sex-stratified analyses. Two genes predicted to be causally relevant to depression by transcriptome-wide association studies ( GPX4 and GYPE ) showed significant DGE. Conclusions: These results are convergent with immunogenetic evidence implicating lymphoid cell dysregulation in depression, while also highlighting histone alterations as a key molecular signature in depression. They also indicate the importance of large-scale datasets for biomarker discovery in the context of heterogeneous disorders like depression.
Open AccessSystematic review and mega-analysis of the peripheral blood transcriptome in depression implicates dysregulation of lymphoid cells and histones
Background: Depression has been associated with transcriptomic changes in peripheral blood. However, the contribution of specific immune cell subsets or pathways remains unclear, and findings have been variable across previous studies, which have not tended to account for sample cellular composition. Methods: We performed a systematic review of peripheral blood transcriptome studies in depression. For the five datasets meeting criteria (total N=6,011), we performed harmonized reprocessing and cell-composition-adjusted differential gene and transcript analyses, followed by a bias- and inflation-adjusted weighted Z-score mega-analysis. We investigated the biological pathways and cell subsets implicated by the results. We also performed a sex-stratified gene network mega-analysis using consensus weighted gene co-expression network analysis (WGCNA). Results: Few genes showed robust differential gene expression (DGE) in depression. Depression was reproducibly associated with decreases in replication-dependent histones, and with a decrease in oxidative phosphorylation pathways in females only. Cell source analyses implicated lymphoid cells (T cells and NK cells) as likely contributors to the depression differential expression signature. WGCNA mega-analysis revealed multiple consensus modules associated with depression, with a PUF60 -related module upregulated in both female and male depression in sex-stratified analyses. Two genes predicted to be causally relevant to depression by transcriptome-wide association studies ( GPX4 and GYPE ) showed significant DGE. Conclusions: These results are convergent with immunogenetic evidence implicating lymphoid cell dysregulation in depression, while also highlighting histone alterations as a key molecular signature in depression. They also indicate the importance of large-scale datasets for biomarker discovery in the context of heterogeneous disorders like depression.
- Open Access
Chronic social defeat stress induces meningeal neutrophilia via type I interferon signaling
Animal models of stress and stress-related disorders are also associated with blood neutrophilia. The mechanistic relevance of this to symptoms or behavior is unclear. We used cytometry, immunohistochemistry, whole tissue clearing, and single-cell sequencing to characterize the meningeal immune response to chronic social defeat (CSD) stress in mice. We find that chronic, but not acute, stress causes meningeal neutrophil accumulation, and CSD increases neutrophil trafficking in vascular channels emanating from skull bone marrow (BM). Transcriptional analysis suggested CSD increases type I interferon (IFN-I) signaling in meningeal neutrophils. Blocking this pathway via the IFN-I receptor (IFNAR) protected against the anhedonic and anxiogenic effects of CSD stress, potentially through reduced infiltration of IFNAR + neutrophils into the meninges from skull BM. Our identification of IFN-I signaling as a putative mediator of meningeal neutrophil recruitment may facilitate development of new therapies for stress-related disorders. One sentence summary: Type I interferon sensing neutrophils accumulate in meninges of psychosocially stressed mice via skull bone marrow channels and are associated with the negative behavioral sequelae of stress; blockade of this pathway inhibits neutrophil trafficking and improves behavioral outcomes.
Open AccessChronic social defeat stress induces meningeal neutrophilia via type I interferon signaling
Animal models of stress and stress-related disorders are also associated with blood neutrophilia. The mechanistic relevance of this to symptoms or behavior is unclear. We used cytometry, immunohistochemistry, whole tissue clearing, and single-cell sequencing to characterize the meningeal immune response to chronic social defeat (CSD) stress in mice. We find that chronic, but not acute, stress causes meningeal neutrophil accumulation, and CSD increases neutrophil trafficking in vascular channels emanating from skull bone marrow (BM). Transcriptional analysis suggested CSD increases type I interferon (IFN-I) signaling in meningeal neutrophils. Blocking this pathway via the IFN-I receptor (IFNAR) protected against the anhedonic and anxiogenic effects of CSD stress, potentially through reduced infiltration of IFNAR + neutrophils into the meninges from skull BM. Our identification of IFN-I signaling as a putative mediator of meningeal neutrophil recruitment may facilitate development of new therapies for stress-related disorders. One sentence summary: Type I interferon sensing neutrophils accumulate in meninges of psychosocially stressed mice via skull bone marrow channels and are associated with the negative behavioral sequelae of stress; blockade of this pathway inhibits neutrophil trafficking and improves behavioral outcomes.